163 related articles for article (PubMed ID: 37311054)
1. Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma.
Chen C; Shin JH; Fang Z; Brennan K; Horowitz NB; Pfaff KL; Welsh EL; Rodig SJ; Gevaert O; Gozani O; Uppaluri R; Sunwoo JB
Cancer Res; 2023 Aug; 83(16):2645-2655. PubMed ID: 37311054
[TBL] [Abstract][Full Text] [Related]
2. NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma.
Brennan K; Shin JH; Tay JK; Prunello M; Gentles AJ; Sunwoo JB; Gevaert O
Sci Rep; 2017 Dec; 7(1):17064. PubMed ID: 29213088
[TBL] [Abstract][Full Text] [Related]
3. Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma.
Farhangdoost N; Horth C; Hu B; Bareke E; Chen X; Li Y; Coradin M; Garcia BA; Lu C; Majewski J
Cell Rep; 2021 Feb; 34(8):108769. PubMed ID: 33626351
[TBL] [Abstract][Full Text] [Related]
4. Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.
Li Y; Goldberg EM; Chen X; Xu X; McGuire JT; Leuzzi G; Karagiannis D; Tate T; Farhangdoost N; Horth C; Dai E; Li Z; Zhang Z; Izar B; Que J; Ciccia A; Majewski J; Yoon AJ; Ailles L; Mendelsohn CL; Lu C
Mol Cell; 2022 Oct; 82(20):3901-3918.e7. PubMed ID: 36206767
[TBL] [Abstract][Full Text] [Related]
5. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
[TBL] [Abstract][Full Text] [Related]
6. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma.
Topchu I; Bychkov I; Gursel D; Makhov P; Boumber Y
bioRxiv; 2023 Sep; ():. PubMed ID: 37786686
[TBL] [Abstract][Full Text] [Related]
7. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
Gameiro SF; Ghasemi F; Zeng PYF; Mundi N; Howlett CJ; Plantinga P; Barrett JW; Nichols AC; Mymryk JS
Infect Agent Cancer; 2021 Feb; 16(1):13. PubMed ID: 33588906
[TBL] [Abstract][Full Text] [Related]
8. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma.
Topchu I; Bychkov I; Gursel D; Makhov P; Boumber Y
Cell Death Discov; 2024 Feb; 10(1):75. PubMed ID: 38346948
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.
Murali M; Saloura V
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
[TBL] [Abstract][Full Text] [Related]
10. Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma.
Secrier M; McGrath L; Ng F; Gulati S; Raymond A; Nuttall BRB; Berthe J; Jones EV; Sidders BS; Galon J; Barrett JC; Angell HK
Cancer Res Commun; 2023 Oct; 3(10):2133-2145. PubMed ID: 37819239
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
12. Disruption of
Bui N; Huang JK; Bojorquez-Gomez A; Licon K; Sanchez KS; Tang SN; Beckett AN; Wang T; Zhang W; Shen JP; Kreisberg JF; Ideker T
Mol Cancer Ther; 2018 Jul; 17(7):1585-1594. PubMed ID: 29636367
[TBL] [Abstract][Full Text] [Related]
13. PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma.
Topchu I; Bychkov I; Roshchina E; Makhov P; Boumber Y
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539515
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
[TBL] [Abstract][Full Text] [Related]
15. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
16. The head and neck cancer immune landscape and its immunotherapeutic implications.
Mandal R; Şenbabaoğlu Y; Desrichard A; Havel JJ; Dalin MG; Riaz N; Lee KW; Ganly I; Hakimi AA; Chan TA; Morris LG
JCI Insight; 2016 Oct; 1(17):e89829. PubMed ID: 27777979
[TBL] [Abstract][Full Text] [Related]
17. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.
Papillon-Cavanagh S; Lu C; Gayden T; Mikael LG; Bechet D; Karamboulas C; Ailles L; Karamchandani J; Marchione DM; Garcia BA; Weinreb I; Goldstein D; Lewis PW; Dancu OM; Dhaliwal S; Stecho W; Howlett CJ; Mymryk JS; Barrett JW; Nichols AC; Allis CD; Majewski J; Jabado N
Nat Genet; 2017 Feb; 49(2):180-185. PubMed ID: 28067913
[TBL] [Abstract][Full Text] [Related]
18. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice.
Brand M; Laban S; Theodoraki MN; Doescher J; Hoffmann TK; Schuler PJ; Brunner C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383676
[TBL] [Abstract][Full Text] [Related]
20. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
